toxicity
hESC derived Cytiva™ Cardiomyocytes for Drug Safety Testing
April 19 by Pharmaceuticals & Biotechnology EditorThis video presentation demonstrates how hESC derived cardiomyocytes can be a powerful approach to assessing cardiac drug liabilities. Nick Thomas describes how hESC derived Cytiva Card...
FDA Representative Gives Insights into Success and Accuracy in Genotoxicity and Carcinogenicity Testing in Exclusive Podcast Interview
September 09 by Pharma IQ NewsPharma IQ has interviewed Dr. Timothy Robison, Pharmacology and Toxicity Reviewer at the US Food & Drug Administration (FDA) and CDER, in an exclusive podcast ahead of his presentations at the Gen...